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ABSTRACT
The state of oligomerization of the tumor
suppressor p53 is an important factor in its various
biological functions. It has a well-defined
tetramerization domain, and the protein exists as
monomers, dimers and tetramers in equilibrium.
The dissociation constants between oligomeric
forms are so low that they are at the limits of meas-
urement by conventional methods in vitro. Here, we
have used the high sensitivity of single-molecule
methods to measure the equilibria and kinetics of
oligomerization of full-length p53 and its isolated
tetramerization domain, p53tet, at physiological
temperature, pH and ionic strength using fluores-
cence correlation spectroscopy (FCS) in vitro. The
dissociation constant at 37 C for tetramers
dissociating into dimers for full-length p53 was
50±7nM, and the corresponding value for dimers
into monomers was 0.55±0.08nM. The half-lives
for the two processes were 20 and 50min, respect-
ively. The equivalent quantities for p53tet were
150±10nM, 1.0±0.14nM, 2.5±0.4min and
13±2min. The data suggest that unligated p53 in
unstressed cells should be predominantly dimeric.
Single-molecule FCS is a useful procedure for
measuring dissociation equilibria, kinetics and
aggregation at extreme sensitivity.
INTRODUCTION
Tumor suppressor p53 decides the fate of cells via tran-
scriptional activation of genes involved in cell-cycle arrest,
apoptosis and DNA repair (1). The quaternary structure
of p53 is composed of both folded and disordered
domains: N-terminal transactivation domain (TAD)
which is intrinsically disordered, folded DNA binding
core domain (CD), structured tetramerization domain
(Tet) and C-terminal negative regulatory domain (CTD)
(Figure 1A) (2). p53 is mutated in  50% of cancers, and
the DNA-binding domain is the main carrier of oncogenic
mutations (3). Cancerous mutants retain their ability to
form tetramers. Hybrid formation between the wild-type
(WT) and mutant protein is proposed as the cause for
trans-dominant effect (gain of mutant function) of the
mutant over WT in heterozygous cells (4). The importance
of the oligomerization domain to p530s function is
evidenced by mutations in this domain identiﬁed in
patients with Li-Fraumeni syndrome (5).
Oligomerization plays an important role in p53 activa-
tion. Tetrameric p53 binds to its DNA response elements
(RE) 100-times more tightly than monomeric core domain
(6). Consequently, tetrameric p53 is required for transac-
tivation of p53 target genes (6–9). Moreover,
post-translational modiﬁcations such as phosphorylation,
acetylation and ubiquitination sometimes require p53 to
be tetramerized (10–12). Experimentally, formation
of tetrameric p53 occurs by the following equilibrium
4M$ 2D$T (where M=monomer, D=dimer and
T=tetramer) (13). Furthermore, p53 dimerizes on
co-translation in polysomes but tetramerization occurs
post-translationally in solution (4).
The dissociation constants between monomer and
dimer, and dimer and tetramer are so low that they are
difﬁcult to be measured accurately. Previous measure-
ments using analytical ultracentrifugation have been
revised to lower values with increasing sensitivity of de-
tectors (14). Furthermore, it has been recently found that
the equilibration is very slow (15). Here, we utilized single-
molecule ﬂuorescence correlation spectroscopy (FCS),
which has the necessary sensitivity to measure the
D$M and T$D equilibrium of p53 tetramerization
domain (p53tet: 325–355) in isolation and in full-length
p53 (ﬂp53: 1–393) at 37 C. We provide a quantitative
analysis of the thermodynamics and kinetics of oligomer-
ization equilibria of p53. The inﬂuence of bax and p21
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rium was also investigated.
Accurate values on the kinetics and equilibrium
constants of p53 oligomerization are not available in lit-
erature, which are essential for the understanding of the
p53 status in normal and tumor cells and how p53 carries
out its functions.
MATERIALS AND METHODS
Materials
Double stranded p21 and bax oligonucleotides labeled
with Atto 655 50-CGCGAACATGTCCCAACATGTTG
CGC-30 and 50-CGCTCACAAGTTAGAGACAA-GCTT
CGC-30 at 50 end were puriﬁed by high-pressure liquid
chromotagraphy (HPLC).
Protein expression, puriﬁcation and labeling
ﬂp53 was expressed and puriﬁed as described (16,17).
Peptides corresponding to residues 325–355 of the
tetramerization domain for the WT, dimeric (L344A)
and monomeric (L344P) carrying an N-terminal cystiene
were purchased from Designer Bioscience Ltd, UK
(>98% HPLC grade purity). Peptides were labeled with
8-fold excess of Atto-655 maleimide (AD 655-45,
ATTO-TEC, Germany) in a buffer containing 20mM
Na2HPO4/NaH2PO4, 100mM NaCl, 3mM TCEP, pH
7.0. Labeling reaction was followed by mass spectrometry.
About 90% of the peptide was labeled by 6h. The mixture
was loaded onto a G-25 desalting column to separate
residual dye. The peptide fraction collected was loaded
onto C-8 column and puriﬁed by high-pressure liquid
chromatography using water-acetonitrile gradient to
separate unlabeled peptide. Atto 655-labeled peptide frac-
tions were collected and freeze-dried. The peptides were
dissolved in buffer containing 20mM Na2HPO4/
NaH2PO4, 150mM NaCl, 3mM DTT, pH 7.4 for future
experiments. ﬂp53 was labeled using Atto-655
succinimidyl ester and puriﬁed as described earlier (18).
FCS experiments
FCS experiments were carried out on a home-built
dual-channel confocal ﬂuorescence microscope set-up
(Nikon Eclipse TE2000-U). Samples were excited using a
Helium-Neon laser at 633nM, with 100mW at the back
aperture of the microscope lens adjusted using neutral
density ﬁlter. Fluorescence was collected using an
oil-immersion objective (Nikon CFIplan Apochromat
VC 100 , numerical aperture 1.4; Nikon), and optically
ﬁltered using a dichroic mirror (Semrock, Brightline,
FF495/540/650) and a long-pass ﬁlter (Semrock, Razor
Edge, 647nm). A pinhole size of 150mm was used to
remove out-of-plane ﬂuorescence photons. The collected
ﬂuorescence light was focused onto an avalanche photon
counting module (SPCM-AQR15; PerkinElmer). The
output from the detector was recorded using a digital
hardware correlator (Flex02-01D/C; Correlator.com).
Temperature was controlled using a custom-built
objective-type heater/cooler. Samples were measured on
Figure 1. Kinetic stability of p53 studied using FCS. (A) Linear repre-
sentation of p53 domain organization. (B) ACFs of WT-ﬂp53, T-ﬂp53
and T-ﬂp53-Y220C measured after 15min. (C) Aggregation kinetics of
WT-ﬂp53 and T-ﬂp53-Y220C. (D) Aggregation kinetics of super-stable
mutant T-ﬂp53 and p53tet.
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with eight wells. Use of Protein blocker (Block Ace,
Snow Brand, Japan) signiﬁcantly reduced the non-speciﬁc
adsorption of proteins on the surface of chamber.
Measurements were made in physiological ionic strength
buffer containing 20mM Na2HPO4/NaH2PO4, pH 7.4,
150mM NaCl, 3mM DTT. 0.05% Tween-20 and
0.3mg/ml BSA were used as solvent additives to further
suppress glass surface adsorption. In FCS experiments to
determine p53 aggregation kinetics, the total concentra-
tion of protein was 2mM (labeled protein concentration
of 0.1nM). For binding experiments, 0.1nM labeled
protein was incubated with increasing amount of un-
labeled protein up to a ﬁnal concentration of 2mM.
Background measurements gave a weak ﬂuorescent
count rate of <10Hz, while the dye-labeled molecules
gave an average count rate of 5KHz. The duration of
each measurement was 180s and each point on the titra-
tion curve is represented by average of three independent
FCS measurements.
FCS data analysis
FCS measures ﬂuorescence intensity ﬂuctuations within
femtoliter detection volumes and a temporal range from
nanoseconds to seconds. Fluorescence ﬂuctuations arising
from single molecules diffusing through the detection
volume in FCS experiments were analyzed via the
second order autocorrelation function [G(t)]:
Gð Þ¼
IðtÞIðt+ Þ

IðtÞ
 2
where I(t) is the ﬂuorescence intensity at time t, I(t+t)i s
the ﬂuorescence intensity after a time lag t, and <>
denotes the time average over the total observation time
(19,20). Data were ﬁtted to an analytical model containing
a single 2D diffusion term described by
Gð Þ¼
1
N
1
1+ = D

where N is average number of ﬂuorescent molecules in the
detection volume, t is the lag time and tD is the experi-
mental diffusion time in two (x,y) dimensions. A 2D
model is of sufﬁcient accuracy where the Z-dimension is
much larger than x/y, which was the case in the experi-
mental set-up used here.
Two independent diffusion species were modeled using:
Gð Þ¼
1
N
1   y
1+ = 1
+
y
1+ = 2

where t1 and t2 are the diffusion times of free protein
and bound complex, y is the amount (mole fraction)
of bound complex. Ensemble measurements conﬁrmed
that the ﬂuorescence intensity and hence the molecular
brightness did not change during any of the binding
events. The least square ﬁt used is based on
the Levenberg-Marquardt algorithm in Origin 7.0
(OriginLab).
Binding and rate data analysis
Binding data for ½p53 +½p  $½ p p53  were analyzed with
simple binding model based on a 1:1 stochiometry for the
bimolecular reaction, where p* represents Atto 655
labeled peptide and p53 represents ﬂp53, using the
equation:
Fb ¼
m ½p53 
Kd+½p53 
+c
where Fb is the fraction of p* bound, m and c are scaling
factors, Kd is the dissociation constant. The following
Kinetic data were ﬁtted to two sequential ﬁrst-order
processes for [p53]4 ! [p53]2 ! [p53], since the change
in equilibrium on dilution was close to irreversible at the
ﬁnal concentration. Data analysis and curve ﬁtting were
performed using Kaleidagraph 4.0.
RESULTS
Determination of stability of p53 with respect to
aggregation using FCS
FCS is a method based on ﬂuctuation analysis of ﬂuores-
cence intensity to characterize time-dependent properties
of individual molecules (21). FCS has been extensively
used to study protein–protein interactions, protein–
ligand binding and large-scale drug screening and more
recently for the study of denatured state dynamics of
small proteins (19,22–25). FCS analysis directly provides
the average number of ﬂuorescent molecules in the obser-
vation volume and the translational diffusion time of mol-
ecules. The latter is proportional to the solution viscosity
and the hydrodynamic radius. The binding or interaction
of proteins can be effectively detected with FCS due to the
third root dependence of hydrodynamic radius on molecu-
lar weight (26).
In contrast to many ensemble techniques, the presence
of even a small amount of aggregates in the sample
material is signaled by species of very slow diffusion
times, typically of the order of a few milliseconds in the
apparatus used. WT p53 is highly unstable with a Tm of
44 C, with reversible denaturation being followed by fast
irreversible aggregation (27). We ﬁrst measured the kinetic
stability (time-dependent aggregation) of ﬂp53 and p53tet
in order to avoid any aggregation in the course of experi-
ments. We assessed in real-time the rate of aggregate
formation of three different forms of ﬂp53: WT
(WT-ﬂp53), a super-stable quadruple mutant (T-ﬂp53)
(28) and a destabilized mutant Y220C in the super-stable
mutant background (T-ﬂp53-Y220C) (Figure 1B). T-ﬂp53
carries four mutations (M133LV203AN239YN268D),
stabilizing p53 by 2.65kcalmol
 1 and increasing its Tm
by 5.6 C (28). The mutant protein T-ﬂp53-Y220C, with
an additional highly destabilizing Y220C mutation (29),
was used as a further control. Proteins were labeled at the
amino terminus using the extrinsic ﬂuorophore Atto 655.
This label is advantageous for FCS studies because of its
insigniﬁcant triplet formation rate, limiting the number of
parameters of ﬁt thereby making the analysis of
2296 Nucleic Acids Research, 2011,Vol.39, No. 6autocorrelation data robust and reliable (30).
Autocorrelation functions (ACF) were measured for dif-
ferent time intervals and the diffusion times were obtained
by ﬁtting the ACFs to single component 2D diffusion
model. Single-component ﬁts of ACFs for samples with
aggregates showed slight deviations in residuals, which is
probably due to the heterogeneous nature of aggregates.
Aggregation of T-ﬂp53-Y220C and WT-ﬂp53 was
observed as early as 5 and 20min, respectively, after
raising the temperature to 37 C, from the appearance of
slowly diffusing species with diffusion time of  2.1ms
(Figure 1C). But, aggregation of T-ﬂp53 was much
slower, occurring after 7.5h (Figure 1D). p53tet was
highly stable and no aggregation was observed even
after incubation at 37 C for 2days.
Tm changes roughly in a linear fashion with change in
free energy of denaturation on mutation but the rate of
unfolding changes in an exponential manner with free
energy change and consequently, an increase in stability
of several kcal mol
 1 can increase the t1/2 of unfolding
from several minutes to a few hours (31). All the experi-
ments in the present study were carried out on the
framework of the super-stable mutant T-ﬂp53 and
p53tet and the total experimental time scale at any point
did not exceed 6.5h at 37 C.
The observed diffusion times of either unbound
molecule or the bound complex and their respective
molecular weights calculated from the diffusion time are
listed in Table 1. Those calculated values of Mw were
higher than the expected and arose most likely because
the spherical shape assumption in the equations does not
hold true, as ﬂp53 is non-globular with intrinsically
disordered TAD and unstructured CTD (2).
Determination of dissociation kinetics and equilibrium
constants of p53tet
We next measured the dissociation kinetics of p53tet to
dimers and monomers. To this end, a working concentra-
tion of 0.1nM of p53tet was achieved by rapid manual
dilution of 1mM of Atto 655-labeled p53tet in the sample
dish of the FCS set-up. ACFs were measured for different
time intervals immediately following dilution (Figure 2A).
Since it was not practically possible to distinguish the dif-
ferent components (bound and unbound) from the
analysis of ACF, an average diffusion time was obtained
by ﬁtting the ACFs to single diffusion component model.
We observed a change in average diffusion time from
183±4 to 115±3ms and this change was statistically sig-
niﬁcant (*P<0.1). Dissociation kinetics was obtained by
plotting the diffusion time against the different time inter-
vals of incubation. Since dissociation of p53tet involves
two equilibria, tetramer-dimer (T $ D) and
dimer-monomer (D $ M), the kinetic plot was ﬁtted
using a double-exponential model (Figure 2B). The ﬁt
results gave t1/2 of 2.5min and 13min for the two
processes at 37 C. We hypothesized that the dissociation
of tetramer to dimer was rapid, with a half-life of 2.5min,
while dimer to monomer transition occurred more slowly.
(A slow step followed by a fast one would give a double
exponential with only a small amplitude for the fast phase,
but we found less than a factor of two difference between
the phases). To check this, we determined the dissociation
kinetics of a dimeric mutant (L344A) that dimerizes but
has impaired tetramerization (32). The t1/2 of 16min for
dimer!monomer is consistent with the dissociation of
p53tet dimer to monomer occurring more slowly than
does tetramer to dimers.
We then determined the dissociation constant (Kd)o f
p53tet to dimers and monomers. ACFs were measured for
the pre-incubated samples of Atto 655-labeled p53tet
(0.1nM) with increasing amounts of unlabeled p53tet
(up to 2mM) (Figure 2C). A single-component ﬁt was
used to deduce the average diffusion time. Binding
curves obtained by plotting the average diffusion time
versus p53 concentration revealed a characteristic
two-step equilibrium (Figure 2D). Fitting of the titration
curve for the T $ D and D $ M equilibrium yielded Kds
of 150nM and 1nM respectively. The two equilibria were
well separated in time by three diffusing species with a lag
time of 113, 145 and 186ms, corresponding to monomers,
dimers and tetramers respectively (see Table 1 for
calculated Mw). Control experiments using Atto
655-labeled L344P p53tet mutant [monomeric mutant
that has impaired oligomerization (32)] showed no
change in diffusion time, conﬁrming that the increase in
diffusion time is due to the progressive formation of
tetramer (Figure 2D).
We choose to perform experiments at 20 and 37 C, as
published experimental results are available for compari-
son for the former while the latter is at physiological tem-
perature and so data recorded under these conditions are
more relevant. The dissociation kinetics and equilibrium
constants were summarized in Table 2.
Determination of dissociation kinetics and equilibrium
constants of T-ﬂp53
We next investigated the kinetics and equilibria of oligo-
merization of ﬂp53, using identical procedures to those
described for p53tet. The dissociation kinetics of ﬂp53
was followed by measuring the average diffusion time at
Table 1. Diffusion times and molecular weight of various protein
samples at 37 C
Sample Diffusion
time (ms)
Mws (kDa)
From FCS
calculated
Mw (KDa)
Free dye 56±2 – 0.6
p53tet (monomer) 114±3 5.0 4.5
p53tet (tetramer) 183±4 21.0 18
T-ﬂp53 (monomer) 243±5 50 44
T-ﬂp53 (tetramer) 390±3 204 175
P21 RE 180±6 20 16
P21 RE+ T-ﬂp53 396±7 212 191
Mw of Atto 655 dye was used as a reference. Mw of different samples,
assuming spherical shape, were calculated using the formula Mwf/
Mws=  (tf/ts)
3, where Mwf and tf, Mws and ts, are molecular
weight and diffusion time of Atto 655 free dye and samples, respect-
ively. Experiments were carried out in triplicates and error
represent±1SD.
Nucleic Acids Research,2011, Vol.39, No. 6 2297regular time intervals (Figure 3A). The dissociation
kinetics of ﬂp53 was  8-fold slower than for p53tet,
with t1/2 of 20min and 50min for the T $ D and D $
M events at 37 C, respectively (Figure 3B).
We next measured the equilibrium constants for the
T $ D and D $ M equilibria. Atto 655 labeled T-ﬂp53
(0.1nM) was incubated with increasing concentrations of
unlabeled p53 for 5h at 37 C. ACFs were measured
Figure 2. Dissociation kinetics and equilibrium constants of p53tet oligomerization measured using FCS. (A) Normalized ACFs following the
dissociation of p53tet at 0, 30 and 150min. (B) Plot of the dissociation kinetics of p53tet with 2-exponential data ﬁt. (C) Binding of 0.1nM Atto
655 labeled p53tet to unlabeled p53tet. ACFs measured at unlabeled p53tet concentrations of 0, 0.05, 0.5 and 2mM is shown. (D) Binding curve
showing the M $ D and D $ T equilibrium of p53tet. Log scale is used along X-axis for clarity. The ﬁrst data point was measured with sample
containing only 0.1nM of labeled p53tet.
Table 2. Equilibrium and half-life of dissociation measured for p53tet and T-ﬂp53
Equilibrium p53tet T-ﬂp53
t1/2 (min) Kd (nM) t1/2 (min) Kd (nM)
20 C3 7  C2 0  C3 7  C2 0  C3 7  C2 0  C3 7  C
T $ D 6.5±0.9 2.5±0.4 60±9 150±14 50±7 20±3 20±3 50±7
D $ M 55±0.8 13±2 0.5±0.07 1±0.14 250±21 50±7  0.2
a 0.55±0.08
T $ D represents tetramer to dimer equilibrium and D $ M represents dimer to monomer equilibrium. p53tet is isolated tetramerization domain
(325–355) and T-ﬂp53 is full-length p53 (1–393) in a super-stable mutant background. Experiments were carried out in buffer containing 25mM
sodium phosphate, 150mM NaCl, 3mM DTT, pH 7.2 at 20 C and 37 C. Experiments were carried out in triplicate and±standard error are
presented.
aNot quantiﬁable accurately because of high afﬁnity for dimerization at 20 C, but is <0.25nM. We estimated the tabulated value from the observed
rate constant for dissociation and an estimated rate constant for association ( 2 10
4s
 1M
 1, see Table 3).
2298 Nucleic Acids Research, 2011,Vol.39, No. 6immediately after incubation (Figure 3C). A progressive
change in the diffusion time from 243±6 to 391±3ms
was observed and this change was statistically signiﬁcant
(*P<0.1). No very slowly diffusing species was observed
during the measurements, indicating the absence of aggre-
gates. Fitting of the plot derived from average diffusion
time of ﬂp53 at various concentrations gave Kdso f5 0n M
and 0.55nM at 37 C for the T $ D and D $ M
equilibria, respectively (Figure 3D). The dissociation con-
stants were  3-fold lower than those for p53tet. Control
experiments using Atto 655-labeled T-ﬂp53-L344P [mono-
meric mutant that has impaired oligomerization (32)]
showed no change in diffusion time upon incuba-
tion with varying amounts of unlabeled T-ﬂp53, thus
conﬁrming the observed change in diffusion time
with Atto 655-labeled T-ﬂp53 was caused by oligomer-
ization (Figure 3D). Table 2 lists the kinetics and equi-
librium quantities measured for ﬂp53 and p53tet at
20 and 37 C.
Rate constants for association
We calculated the rate constants for association (kass)o f
monomers to dimers and dimers to tetramers from the rate
constants for dissociation and the Kds (Table 3). The kasss
were much smaller than diffusion-controlled limit,
indicating a complex energy barrier-limited binding
process rather than a diffusion-controlled one.
Inﬂuence of DNA on the tetramerization equilibrium
of p53
We next investigated how addition of DNA inﬂuences the
D $ T equilibrium. For this purpose, we used Atto
655-labeled p21 response element (26bp) and Atto
655-labeled bax response element (27bp) in FCS experi-
ments. p21 RE and bax RE are two of the many
p53-target genes that directly mediate cell-cycle arrest
and apoptosis respectively (1). p53 binds to p21 and
bax response elements with Kdso f 8 and 184nM
Figure 3. Dissociation kinetics and equilibrium constants of T-ﬂp53 oligomerization measured using FCS. (A) Normalized ACFs following the
dissociation of T-ﬂp53 at 0, 30 and 150min. (B) Plot of the dissociation kinetics of T-ﬂp53 with 2-exponential ﬁt. (C) Binding of 0.1nM Atto 655
labeled T-ﬂp53 to unlabeled T-ﬂp53. ACFs measured at unlabeled T-ﬂp53 concentrations of 0, 0.05, 0.5 and 2mM is shown. (D) Binding curve
showing the M $ D and D $ T equilibrium of ﬂp53. Log scale is used along X-axis for clarity. The ﬁrst data point was measured with sample
containing only 0.1nM of labeled ﬂp53.
Nucleic Acids Research,2011, Vol.39, No. 6 2299respectively (15). The diffusion times of Atto 655-labeled
p21 RE and bax RE were measured to be 180 and 183ms,
respectively (Figure 4A). We measured ACFs for a
mixture containing Atto 655-labeled bax (5nM) and un-
labeled T-ﬂp53 (10nM). At a concentration of 10nM, p53
is predominantly dimeric as measured earlier. No signiﬁ-
cant change in diffusion time, compared with free bax RE,
was observed for the complex (Figure 4B). Under the
same experimental conditions, the inﬂuence of p21 on
the D $ T equilibrium was investigated. ACF was
measured upon addition of unlabeled protein, but the
ﬁtting of ACF to a single component 2D model yielded
a poor ﬁt (Figure 4C). Hence a two-diffusion component
model was used keeping the diffusion time of free p21
(180ms) as a ﬁxed parameter in the ﬁt. The ﬁtting
quality improved signiﬁcantly and yielded a diffusion
time of 396ms for the slowly diffusing component
(Figure 4D). Using Atto 655 labeled p21 as reference
with t=180ms and Mw=16kDa, the apparent Mw of
the complex with t=396ms was  212kDa (calculated
Figure 4. DNA binding experiments of T-ﬂp53 to Atto 655 labeled p21 and bax RE. (A) ACF of Atto 655-labeled p21 RE. Fitting to a single
diffusion model yielded t of 180ms. (B) FCS curve of sample containing 10nM T-ﬂp53 and 5nM Atto 655 labeled bax RE. No difference in diffusion
time as compared to free Atto 655 labeled bax RE was observed. (C) Single component ﬁt of the ACF obtained from the sample containing 10nM of
T-ﬂp53 and 5nM of Atto 655 labeled p21 RE. Residual of the ﬁt is shown in green. (D) Two-component ﬁt of the ACF of sample containing 10nM
of T-ﬂp53 and 5nM of Atto 655 labeled p21 RE (t=180 and 396ms). Residual of the ﬁt is shown in green.
Table 3. Kinetic rate constants measured for p53tet and T-ﬂp53
Reaction p53tet T-ﬂp53
kass (s
 1M
 1) kdiss (s
 1) kass (s
 1M
 1) kdiss (s
 1)
20 C3 7  C2 0  C3 7  C2 0  C3 7  C2 0  C3 7  C
T $ D3  10
4 3.1 10
4 1.8 10
 3 4.6 10
 3 1.2 10
4 1.2 10
4 2.3 10
 4 5.8 10
 4
D $ M 4.2 10
5 8.9 10
5 2.1 10
 4 8.9 10
 4 – 4.2 10
5 4.6 10
 5 2.3 10
 4
The rate constants for association, kass, are calculated from Kd and the rate constant kdiss measured from FCS experiments.
2300 Nucleic Acids Research, 2011,Vol.39, No. 6using the relation Mwf/Mws=  (tf/ts)
3, using Atto 655
dye as reference, see Table 1 for details). This is close to
the theoretical molecular weight of [p53]4:[p21 DNA]
complex (192KDa). An apparent Kd of  7nM was
estimated from the amplitudes of free p21 RE and the
bound complex, which is in good agreement with
previous results (15). Lack of binding in control experi-
ments using the full-length p53 R273H mutant that has
impaired DNA-binding ability (33) conﬁrmed that the for-
mation of [p53]4:[p21 DNA] complex resulted from the
sequence-speciﬁc DNA binding of p53. The
sequence-speciﬁc binding of bax RE was not detected
because its Kd  184nM is too high (15).
DISCUSSION
We investigated the dissociation kinetics and thermo-
dynamic equilibria of tetramer–dimer–monomer transi-
tions of full-length p53 and p53tet using ﬂuorescence
correlation spectroscopy. We ﬁrst measured the lag
phase in the kinetics of aggregation (Figure 1) to make
sure that our data were collected prior to any artifacts
arising from irreversible events.
Analytical ultracentrifugation (AUC) has previously
been used to characterize the tetramerization equilibria
of p53 (14,16,34). Earlier measurements using absorbance
detection, tended to give values of  100–140nM for the
dissociation constant of the tetramer–dimer equilibrium,
and were too insensitive to detect the dimer–monomer
stage (35). Use of ﬂuorescence detection gives a Kd of
19.4±8.8nM for tetramers to dimers and 1.0±0.7nM
for dimers to monomers at 10 C in a similar buffer to ours
but containing 10% glycerol (14). The value of 1nM is at
the very limit of detection of current AUC detection
because experiments have to be performed at concentra-
tions of reagents around their Kd. We obtained reliable
data at 37 C of 50±7nM for tetramer to dimer and
0.55±0.08 for dimer to monomer (Table 2). At 20 C,
the dimer-monomer equilibrium was too low to measure,
and was estimated to be <0.25nM. We can calculate an
approximate value to be  0.2nM from the ratio of the
rate constant for dissociation of the dimer to that
estimated by comparison for the association of full-
length tetramers at 20 C (see note to Table 2).
The rate constants for association of dimers to tetra-
mers and monomers to dimers were calculated from the
measured rate and equilibrium constants for dissociation
(Table 3). The rate constant for the association of p53tet
at 25 C was previously measured from protein folding
studies under somewhat different conditions to be
3.1 10
5s
 1M
 1, and the dissociation rate constant for
p53tet tetramer 3.7 10
 3 s
 1 (13), which are in reason-
able agreement with values in Table 3 (4.2 10
5 s
 1 and
1.8 10
 3s
 1, respectively). The rate constants for the as-
sociation of p53tet are 2- to 3-fold higher than for
full-length p53. A major contributory factor is the
slower rate of diffusion of the large molecules (Table 1),
since the target size of the association region is the same
for both proteins.
The self-association of full-length p53 is stronger than
that for p53tet, by a factor of 3 for dimers to tetramers,
and a factor of 2 for monomers to dimers (Table 2).
The major reason for tighter binding in both cases is
slower dissociation constants, which will reﬂect a slower
diffusion apart, which balances the slower diffusion
together, combined with some known weak CD:CD
interactions(2,35).
This study demonstrates the power of FCS as a quan-
titative protein binding assay for tight binders due to its
single-molecule sensitivity (detection limit being low pM).
The slow dissociation kinetics competing with spontan-
eous denaturation of WT p53 has direct implications in
the dominant negative effect exerted by hetero-
oligomerization with mutant p53.
Biological implications
Although the measurements of dissociation constants in
the present study were in vitro, they were measured
at physiological temperature, pH and ionic strength, and
so do have some bearing on in vivo, especially as the
dissociation constants for monomer–dimer and dimer–
tetramer differ by 100-fold. p53 protein levels are
normally low in unstressed cells due to rapid turnover,
but in response to various stress stimuli, p53 is stabilized
leading to higher levels and activated. The actual cellular
concentration of p53 has not been measured experimen-
tally to date, although a basal level of 1–10nM has been
suggested (34). If this number holds true, then p53 exists
predominantly as dimers in the cellular pool. However,
due to the high afﬁnity of p53 dimer to p21 response
element (which is much higher than the inherent dissoci-
ation constant of p53 tetramer), a major fraction of p53
is expected to be bound to p21 response element (or any
promoters of similar afﬁnity). Hence, upon stress, only an
activation signal (such as posttranslational modiﬁcations)
is necessary to begin transactivation. However, for trans-
activation of promoters such as bax, enough p53 has to be
accumulated before binding to the response element.
Consequently, following stress stimuli, p53 levels must
increase for transactivation of bax to occur. In support
of this hypothesis, using CHIP experiments it has been
shown that p53 is bound to p21 promoter in unstressed
cells. Further induction of p21 occurs rapidly upon stress.
On the other hand, little p53 is bound to bax promoter in
unstressed cells and induction of bax occurs with delayed
kinetics (36).
But, superimposed upon the equilibria of unligated p53
is a complex regulation of the oligomeric state of p53 by
partner proteins. p53-interacting proteins such as 14-3-3,
Ref-1, BCCIP, c-Abl, provides another layer in the func-
tional activation of p53 by facilitating p53 tetramerization
(16,37). Furthermore, cellular function of p53 is tightly
regulated at the level of p53 transcription and protein
stability. This is often achieved by posttranslational modi-
ﬁcations and protein–protein interactions, which lead to
either increased stability or degradation (1,38). For
instance, the S100 family of proteins (S100A4 and
S100B) binds to monomeric, dimeric or tetrameric forms
of p53 and in turn regulate its activity (39,40). Binding of
Nucleic Acids Research,2011, Vol.39, No. 6 2301S100 to monomeric or dimeric forms is proposed to
deregulate the activity of p53 (39). However, in order
to disrupt tetramerization, S100B must compete for the
dimer-tetramer equilibrium. The afﬁnity of S100B to
tetramerization domain of p53 ( 50mM) is much weaker
than the inherent p53 tetramerization, as measured here
and, therefore, high levels of S100B is necessary to disrupt
tetramerization and impair p53 function (39). In support
of this idea, it has been shown that very high levels of
S100B, as observed in some tumors, prevent p53
tetramerization and consequently inhibit its activity (41).
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